MLchartDataset catalogue

Diazooxonorleucine

Term · Oncology and biomedicine · MLC-T-ONC-013037

An L-glutamine diazo analogue amino acid antibiotic isolated from a species of the bacterial genus Streptomyces with potential antineoplastic activity. Diazooxonorleucine inhibits several glutamine-dependent biosynthetic pathways involved in the the syntheses of D-glucosamine phosphate, purines and pyrimidines. This agent inhibits phosphate-activated glutaminase, a key enzyme for the synthesis of releasable glutamine, depleting cells of this essential amino acid and reducing their capacity to proliferate.

Table 1. Record
IdentifierMLC-T-ONC-013037
FieldOncology and biomedicine
AbbreviationDON
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013037",
  "term": "Diazooxonorleucine",
  "field": "Oncology and biomedicine",
  "definition": "An L-glutamine diazo analogue amino acid antibiotic isolated from a species of the bacterial genus Streptomyces with potential antineoplastic activity. Diazooxonorleucine inhibits several glutamine-dependent biosynthetic pathways involved in the the syntheses of D-glucosamine phosphate, purines and pyrimidines. This agent inhibits phosphate-activated glutaminase, a key enzyme for the synthesis of releasable glutamine, depleting cells of this essential amino acid and reducing their capacity to proliferate.",
  "abbreviation": "DON",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/diazooxonorleucine/"
}

Record 5,953 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.